Skip to main content
. 2015 Mar 1;9(3):FC05–FC09. doi: 10.7860/JCDR/2015/11884.5677

[Table/Fig-3]:

Comparison of change in OABSS and its individual subjective symptoms

Darifenacin Trospium
Baseline score 4 week score Change in score from baseline % change Baseline score 4 week score Change in score from baseline % change
Mean ± SD Mean ± SD
Frequency 1.00 ± 0.74 0.20 ± 0.55 -0.80 ± 0.76 80.00 0.53 ± 0.73 0.07 ± 0.25 -0.47 ± 0.63 86.79
Nocturia 2.80 ± 0.85 1.93 ± 1.08 -0.87 ± 0.90 31.07 2.27 ± 1.01 1.33 ± 0.96 -0.93 ± 0.79 41.41
Urgency 3.40 ± 1.99 1.53 ± 2.22 -1.87 ± 2.22 55.00 3.87 ± 1.61 1.47 ± 2.13 -2.40 ± 2.19 62.02
Urge urinary incontinence 2.67 ± 1.95 0.40 ± 1.04 -2.27 ± 1.72 85.02 2.60 ± 2.03 1.13 ± 1.78 -1.47 ± 1.96 56.54
OABSS 9.87 ± 3.75 4.07 ± 3.29 -5.80 ± 3.99 58.76 9.27 ± 3.21 4.00 ± 3.86 -5.27 ± 2.98 56.85